6
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Lack of 64,000-MR Islet Autoantigen Overexpression and Antibody Development Following Coxsackievirus B4 Infection in Diabetes-Resistant Mice

&
Pages 197-203 | Received 21 Jun 1992, Accepted 25 Sep 1992, Published online: 07 Jul 2009
 

Abstract

Congenic B10.BR/SgSnJ H-2kTla2 mice were infected with a diabetogenic strain of coxsackievirus CB4 to correlate abnormalities of sugar metabolism with virus replication in islets, 64.000-Mr (64K) islet autoantigen expression, 64K antibody development, and pancreas histopathology in early and late infection. Plaque assay was used to measure virus replication, whereas immunoprecipitation of the mouse islet extracts with 64K antibody-positive and -negative human sera measured autoantigen expression and antibody development. The infected mice exhibited blood glucose values below that of the noninfected control animals at 72 h postinfection, this subnormal blood glucose persisted at 6 wk postinfection and later. A baseline expression of the autoantigen was detected in the noninfected mice; however, the infected animals did not overexpress the protein at 72 h postinfection or develop 64K antibodies after infection. Limited virus replication was detected in the islets at 72 h postinfection but not later. Acinar necrosis, but not islet loss due to mononuclear cell infiltration, was evident in the infected mice. The congenic mice did not develop hyperglycemia and appear to be diabetes-resistant, their beta cells were largely preserved. This may be due to limited virus replication in their islets or their failure to overexpress the autoantigen and develop 64K antibodies following the infection. Diabetes-susceptible mice, on the contrary, support active virus replication in their islets. overexpress the autoantigen at 72 h postinfection, and develop 64K antibodies and hyperglycemia following such infection (Gerling et al., 1988, 1991).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.